SINOVAC BIOTECH LTD Retained Earnings
SINOVAC BIOTECH LTD (SVA) had Retained Earnings of $2.82 billion as of 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent › Retained Earnings (Accumulated Deficit)
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-06-05
- 2025-12-31: Retained Earnings (Accumulated Deficit) $2.82B.
- 2024-12-31: Retained Earnings (Accumulated Deficit) $6.84B.
- 2023-12-31: Retained Earnings (Accumulated Deficit) $6.79B; Retained Earnings (Accumulated Deficit) as first filed $7.12B.
- 2022-12-31: Retained Earnings (Accumulated Deficit) $6.80B; Retained Earnings (Accumulated Deficit) as first filed $7.23B.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2025-12-31 | $2.82B 20-F · filed 2026-06-05 | |
| 2024-12-31 | $6.84B 20-F · filed 2026-06-05 | |
| 2023-12-31 | $6.79B 20-F · filed 2026-04-30 | $7.12B 20-F · filed 2024-04-29 |
| 2022-12-31 | $6.80B 20-F · filed 2026-04-30 | $7.23B 20-F · filed 2023-05-01 |
| 2021-12-31 | $6.81B 20-F · filed 2026-04-30 | $7.14B 20-F · filed 2022-04-29 |
| 2020-12-31 | $144.24M 20-F · filed 2022-04-29 | |
| 2019-12-31 | $56.73M 20-F · filed 2021-04-22 | |
| 2018-12-31 | $23.82M 20-F · filed 2020-04-30 | |
| 2017-12-31 | $9.13M 20-F · filed 2019-04-29 | |
| 2016-12-31 | -$11.91M 20-F · filed 2018-05-11 | |
| 2015-12-31 | -$9.98M 20-F · filed 2017-11-22 | -$8.28M 20-F · filed 2016-04-25 |
| 2014-12-31 | -$6.38M 20-F · filed 2016-04-25 | |
| 2011-12-31 | $2.70M 20-F · filed 2012-04-12 | |
| 2010-12-31 | $3.88M 20-F · filed 2012-04-12 |